Topics

The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/37qfEeU 

18:00 EST 14 Feb 2020 | STAT

The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/37qfEeU 

Original Article: The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/37qfEeU 

NEXT ARTICLE

More From BioPortfolio on "The Japanese drug maker Eisai said it would withdraw the weight-loss drug Belviq from the U.S. market after the FDA expressed concerns about an increased occurrence of cancer reported in people who used the product. https://buff.ly/37qfEeU "

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...